Poseida.jpg
Poseida Therapeutics Raises $142 Million in Series C Financing
22 avr. 2019 07h00 HE | Poseida Therapeutics, Inc.
SAN DIEGO, April 22, 2019 (GLOBE NEWSWIRE) -- Poseida Therapeutics Inc., a clinical-stage biopharmaceutical company leveraging proprietary non-viral gene engineering technologies to create...
Cambia Health Solutions hires Alison Esquea as Vice President of Federal Affairs
21 févr. 2019 08h04 HE | Cambia Health Solutions
PORTLAND, Ore., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cambia Health Solutions is pleased to announce that the Public Affairs and Policy team has hired Alison Esquea as Vice President of Federal Affairs,...
Stephan Jackman
Alzamend Neuro™ Appoints New CEO, Bio-Pharma Executive Stephan Jackman
20 nov. 2018 09h00 HE | Alzamend Neuro, Inc.
Salt Lake City, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it has appointed bio-pharma executive, Mr. Stephan Jackman, as its new Chief...
Rhizen Pharmaceutica
Rhizen Pharmaceuticals Announces Exclusive Worldwide License Agreement for the Development and Commercialization of a Dual PI3K-delta gamma Inhibitor
09 déc. 2015 07h00 HE | Rhizen Pharmaceuticals SA
La Chaux-de-Fonds, Switzerland , Dec. 09, 2015 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A. announced today that they have entered into an exclusive, worldwide license agreement with Novartis for...
Pharmaceutical Executive Joins Mesoblast As Chief Financial Officer
24 août 2014 21h16 HE | Mesoblast
NEW YORK and MELBOURNE, Australia, Aug. 24, 2014 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX: MSB; USOTC: MBLTY) today announced the appointment of pharmaceutical executive Mr Paul Hodgkinson as...
Roche Holding Tops List of Switzerland's Most Honored Companies in Institutional Investor's All-Europe Executive Team Ranking
25 mars 2014 03h00 HE | Institutional Investor
NEW YORK, NY--(Marketwired - Mar 25, 2014) - Roche Holding's CEO Severin Schwan claims victory as one of the Pharmaceuticals sector's best executives in the 2014 All-Europe Executive Team,...
Key Pharmaceutical Executive Joins Mesoblast
10 mars 2014 19h48 HE | Mesoblast
NEW YORK and MELBOURNE, Australia, March 10, 2014 (GLOBE NEWSWIRE) -- Regenerative medicine company Mesoblast Limited (ASX:MSB; USOTC:MBLTY) today announced that Jonathan R. Symonds, CBE, the former...
Documents Uncovered by Judicial Watch Detail Big Pharma Campaign Access to Democratic Governors During 2012 National Governors Association Meeting
28 mars 2012 14h11 HE | Judicial Watch
WASHINGTON, DC--(Marketwire - Mar 28, 2012) - Judicial Watch, the public interest group that investigates and prosecutes government corruption, announced today that it has uncovered documents...
Invivoscribe Announces Collaboration Agreement to Develop Companion Diagnostic Test
15 févr. 2011 16h00 HE | Invivoscribe Technologies, Inc.
SAN DIEGO, CA--(Marketwire - February 15, 2011) - Invivoscribe™ Technologies, Inc., a world leader in personalized molecular medicine, announced today that they have entered into a...
MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New Technologies Create Global Opportunities"
04 nov. 2009 15h40 HE | MIT Enterprise Forum of Cambridge
CAMBRIDGE, MA--(Marketwire - November 4, 2009) - On November 9, the MIT Enterprise Forum of Cambridge will present a session on the development of new technologies for the research, development and...